Class IITerminated in FDA datasetRecall initiated Feb 13, 2017

Pharmanex Cholestin. Cholesterol Health. 60 Softgels.

Recalling firm: Nu Skin Enterprises Inc.

Why it was recalled

Nu Skin announces a voluntary field action for Pharmanex Cholestin due to undeclared allergen; soy.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Aug 22, 2017.

Check your package

Compare the exact product and package details with the label you have.

ProductPharmanex Cholestin. Cholesterol Health. 60 Softgels.

FDA code information

Batch: CS10351

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Pharmanex Cholestin. Cholesterol Health. 60 Softgels.

Extracted codes and context

TypeCode / valueContext
batchCS10351Batch: CS10351

Original FDA recall reason

Nu Skin announces a voluntary field action for Pharmanex Cholestin due to undeclared allergen; soy.

Recall details

Recall number
F-1580-2017
Event ID
76535
FDA status
Terminated
Initiated
Feb 13, 2017
Reported
Mar 15, 2017
Classified
Mar 8, 2017
Terminated
Aug 22, 2017
Quantity
7,327
Location
Provo, UT, United States
Initiation type
Voluntary: Firm initiated
Notification
E-Mail

Where it was distributed

Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.

FDA source record · F-1580-2017

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.